ARCHIVES

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

CHMP Delivers Positive Opinion For Two-Dose HPV Vaccine

February 28, 2014

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

FDA Relies on Importation, Fast Approval, and Early Reporting to Combat Drug Shortages

February 24, 2012

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

July 4, 2014

First “Annual” CCOP RFA Issued; Research Bases Must Compete

June 8, 1990